[LHN]
Subscribe
Open menu
MethodologySubmit a ClaimMedical Disclaimer

Is dasatinib plus quercetin a DIY longevity protocol?

Dasatinib plus quercetin is promoted online as a self-directed senolytic protocol.

Simple answer

Dasatinib plus quercetin should not be treated as a DIY longevity routine. Dasatinib is a prescription oncology drug, and senolytic research does not justify self-directed use. The safer reading is: do not treat social media or clinic marketing as proof, and do not use this page for medical decisions.

Bottom line at a glance

Bottom line:RiskyEvidence:Trial registeredRisk:High riskStatus:Off-label
What does evidence mean?
A study exists or is planned; registration is not proof of benefit.
Why risk matters
Do not use this page for dosing, sourcing or self-administration decisions.
Approval status
A clinician may use an approved medicine outside its approved label.

Last checked: Jun 27, 2026

What people claim

The claim takes an investigational drug combination and reframes it as a consumer routine.

What we know

  • Senolytic research is real but still developing.
  • Dasatinib has serious medical context and is not a wellness supplement.
  • Research combinations require clinician and trial-level safeguards.

What we do not know

  • It does not prove healthy adults should use the combination.
  • It does not prove anti-aging benefit.
  • It does not remove prescription-drug risks.

What should you do with this information?

  • Use it to ask better questions, not to self-experiment.
  • Do not use this page for dosing, sourcing, stacking or self-administration decisions.
  • Speak with a qualified clinician before acting on high-risk claims.

What not to do

  • Do not self-administer based on this page.
  • Do not use this page for dosing, sourcing, stacking, cycle planning or injection instructions.
  • Do not start, stop or combine drugs, peptides, supplements or experimental interventions without a qualified clinician.

Questions to ask a qualified clinician

  1. What exact medical indication is being discussed, and is it approved for that use?
  2. What human evidence exists for my situation, not just animals, cells or biomarkers?
  3. What monitoring, contraindications and interaction questions matter before any decision?
  4. What outcome would show benefit, and what outcome would show harm or no effect?

Want the deeper version?

Open these sections if you want the source detail, regulatory context and expert notes.

Show the evidenceSources, study type and where the claim gets weaker.+
Clinicaltrials

Shows registered senolytic studies and populations.

Publisher
ClinicalTrials.gov
Accessed
Jun 27, 2026
Study type
Regulatory Document

Limitations: Trial registration does not prove benefit; it shows a study has been registered.

Fda

Dasatinib is a prescription drug with specific approved uses.

Publisher
FDA
Accessed
Jun 27, 2026
Study type
Regulatory Document

Limitations: Regulatory status is use-specific and can change; readers should verify current labels and official notices.

Weakest link in the claim

  • The weak link is converting research into self-directed longevity use.
Show regulatory detailApproval status is use-specific. Internet claims may not match reviewed uses.+
Status:Off-labelWho might profit:Influencer/product claim
Show expert notesWhat would change our mind, money trail and related claims.+

What would change our mind

  • Large controlled trials with safety and clinical outcomes.
  • Clear approved indication and population.
  • Guidelines from qualified clinical bodies.

Money trail

Who might profit:Influencer/product claim

Commercial context does not automatically make a claim false, but it changes how carefully the claim should be read.

  • Forum and influencer content can turn research into a routine; that incentive is not the same as medical evidence.

FAQs

Does this page give a protocol?

No. LHN claim checks explain evidence, risk, regulatory status and source context. They do not provide personal medical instructions.

Is this a supplement-style senolytic stack?

No. LHN classifies the DIY claim as risky and inappropriate for self-direction.

Related claims

Longevity drugs

Does rapamycin slow aging in humans?

Rapamycin has unusually strong aging-biology interest, but it is not proven to slow human aging or extend lifespan in healthy adults.

Evidence:Human trial evidenceRisk:High risk

Updated Jun 27, 2026 · Promising, not settled

Read the simple answer

Related guides

Get the weekly longevity evidence briefing.

One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims.

No protocols. No miracle claims. No spam.

I'm new to longevityPeptides and regulationRapamycin and longevity drugsNAD and supplementsGene therapy frontierBiological age and testing